NDC 23155-645

LOSARTAN POTASSIUM 50 mg

Losartan Potassium

LOSARTAN POTASSIUM 50 mg is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Heritage Pharmaceuticals Inc.. The primary component is Losartan Potassium.

Product ID23155-645_69092b0c-ce00-40b1-b56c-85a27d4c7430
NDC23155-645
Product TypeHuman Prescription Drug
Proprietary NameLOSARTAN POTASSIUM 50 mg
Generic NameLosartan Potassium
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2018-01-04
Marketing CategoryANDA / ANDA
Application NumberANDA090382
Labeler NameHeritage Pharmaceuticals Inc.
Substance NameLOSARTAN POTASSIUM
Active Ingredient Strength50 mg/1
Pharm ClassesAngiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 23155-645-03

30 TABLET, FILM COATED in 1 BOTTLE (23155-645-03)
Marketing Start Date2018-01-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 23155-645-03 [23155064503]

LOSARTAN POTASSIUM 50 mg TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090382
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-01-04
Inactivation Date2020-01-31

NDC 23155-645-09 [23155064509]

LOSARTAN POTASSIUM 50 mg TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090382
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-01-04
Inactivation Date2020-01-31

NDC 23155-645-10 [23155064510]

LOSARTAN POTASSIUM 50 mg TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090382
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-01-04
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
LOSARTAN POTASSIUM50 mg/1

OpenFDA Data

SPL SET ID:a3f034a4-c65b-4f53-9f2e-fef80c260b84
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 979485
  • 979492
  • 979480
  • Pharmacological Class

    • Angiotensin 2 Receptor Antagonists [MoA]
    • Angiotensin 2 Receptor Blocker [EPC]

    Medicade Reported Pricing

    23155064510 LOSARTAN POTASSIUM 50 MG TAB

    Pricing Unit: EA | Drug Type:

    23155064509 LOSARTAN POTASSIUM 50 MG TAB

    Pricing Unit: EA | Drug Type:

    23155064503 LOSARTAN POTASSIUM 50 MG TAB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "LOSARTAN POTASSIUM 50 mg" or generic name "Losartan Potassium"

    NDCBrand NameGeneric Name
    23155-645LOSARTAN POTASSIUM 50 mgLOSARTAN POTASSIUM 50 mg
    62980-502LOSARTAN POTASSIUM 50 mgLOSARTAN POTASSIUM 50 mg
    64380-934LOSARTAN POTASSIUM 50 mgLOSARTAN POTASSIUM 50 mg
    68071-5146LOSARTAN POTASSIUM 50 mgLOSARTAN POTASSIUM 50 mg
    70518-2530LOSARTAN POTASSIUM 50 mgLOSARTAN POTASSIUM 50 mg
    72789-164LOSARTAN POTASSIUM 50 mgLOSARTAN POTASSIUM 50 mg
    70934-781LOSARTAN POTASSIUM 50 mgLOSARTAN POTASSIUM 50 mg
    0006-0951COZAARlosartan potassium
    0006-0952COZAARlosartan potassium
    0006-0960COZAARlosartan potassium
    0054-0123Losartan PotassiumLosartan Potassium
    0054-0124Losartan PotassiumLosartan Potassium
    0054-0125Losartan PotassiumLosartan Potassium
    0093-7364Losartan PotassiumLosartan Potassium
    0093-7365Losartan PotassiumLosartan Potassium
    0093-7366Losartan PotassiumLosartan Potassium
    0179-0200Losartan PotassiumLosartan Potassium
    0179-0202Losartan PotassiumLosartan Potassium
    0179-0203Losartan PotassiumLosartan Potassium
    0615-7604Losartan PotassiumLosartan Potassium
    0615-7605Losartan PotassiumLosartan Potassium
    0615-7606Losartan PotassiumLosartan Potassium
    0615-7958Losartan PotassiumLosartan Potassium
    0615-7959Losartan PotassiumLosartan Potassium
    0615-7960Losartan PotassiumLosartan Potassium
    0615-8207Losartan PotassiumLosartan Potassium
    0615-8208Losartan PotassiumLosartan Potassium
    0615-8209Losartan PotassiumLosartan Potassium
    0781-5700Losartan potassiumlosartan potassium
    0781-5701Losartan potassiumlosartan potassium
    0781-5702Losartan potassiumlosartan potassium

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.